These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7675372)
1. Body fat distribution in women with polycystic ovary syndrome. Douchi T; Ijuin H; Nakamura S; Oki T; Yamamoto S; Nagata Y Obstet Gynecol; 1995 Oct; 86(4 Pt 1):516-9. PubMed ID: 7675372 [TBL] [Abstract][Full Text] [Related]
2. Body fat composition and distribution in women with polycystic ovary syndrome. Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379 [TBL] [Abstract][Full Text] [Related]
3. Serum androgen levels and muscle mass in women with polycystic ovary syndrome. Douchi T; Yamamoto S; Oki T; Maruta K; Kuwahata R; Nagata Y Obstet Gynecol; 1999 Sep; 94(3):337-40. PubMed ID: 10472855 [TBL] [Abstract][Full Text] [Related]
4. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
5. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Yucel A; Noyan V; Sagsoz N Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726 [TBL] [Abstract][Full Text] [Related]
6. Relationships among serum testosterone levels, body fat and muscle mass distribution in women with polycystic ovary syndrome. Douchi T; Yoshimitsu N; Nagata Y Endocr J; 2001 Dec; 48(6):685-9. PubMed ID: 11873867 [TBL] [Abstract][Full Text] [Related]
7. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Kirchengast S; Huber J Hum Reprod; 2001 Jun; 16(6):1255-60. PubMed ID: 11387301 [TBL] [Abstract][Full Text] [Related]
8. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189 [TBL] [Abstract][Full Text] [Related]
9. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997 [TBL] [Abstract][Full Text] [Related]
10. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879 [TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and body composition in lean women with polycystic ovary syndrome. Good C; Tulchinsky M; Mauger D; Demers LM; Legro RS Fertil Steril; 1999 Jul; 72(1):21-5. PubMed ID: 10428143 [TBL] [Abstract][Full Text] [Related]
12. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls. Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Glintborg D; Andersen M; Hagen C; Frystyk J; Hulstrøm V; Flyvbjerg A; Hermann AP Eur J Endocrinol; 2006 Aug; 155(2):337-45. PubMed ID: 16868149 [TBL] [Abstract][Full Text] [Related]
14. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302 [TBL] [Abstract][Full Text] [Related]
15. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients. Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253 [TBL] [Abstract][Full Text] [Related]
16. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome? Szydlarska D; Grzesiuk W; Trybuch A; Kondracka A; Kowalik I; Bar-Andziak E Endokrynol Pol; 2012; 63(5):356-61. PubMed ID: 23115068 [TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Gonzalez F; Thusu K; Abdel-Rahman E; Prabhala A; Tomani M; Dandona P Metabolism; 1999 Apr; 48(4):437-41. PubMed ID: 10206434 [TBL] [Abstract][Full Text] [Related]
19. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies? Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052 [TBL] [Abstract][Full Text] [Related]
20. Android fat distribution affects some hemostatic parameters in women with polycystic ovary syndrome compared with healthy control subjects matched for age and body mass index. de Mendonça-Louzeiro MR; Annichino-Bizzacchi JM; Benetti-Pinto CL Fertil Steril; 2015 Aug; 104(2):467-73. PubMed ID: 26051101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]